US Federal 2025-2026 Regular Session

House Energy and Commerce Committee Bills & Legislation (Page 34)

US

US Federal 2025-2026 Regular Session

US Federal House Bill HR119

Introduced
2/6/25  
Declaring racism a public health crisis.
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1082

Introduced
2/6/25  
Refer
2/6/25  
Report Pass
4/29/25  
Shandra Eisenga Human Cell and Tissue Product Safety Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1059

Introduced
2/6/25  
Jobs and Opportunities for Medicaid Act This bill establishes work requirements under Medicaid for able-bodied adults. Specifically, the bill requires individuals who are between the ages of 18 and 65 and who are not otherwise unable to work due to a medical condition, family situation, or other listed reason to work or volunteer at least 20 hours per week, based on a monthly average, in order to qualify for Medicaid.
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1064

Introduced
2/6/25  
Stopping Overdoses of Fentanyl Analogues ActThis bill permanently adds fentanyl-related substances to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires March 31, 2025.
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1052

Introduced
2/6/25  
Refer
2/6/25  
UNPLUG EVs Act Undoing Nationwide Programs and Limiting Unnecessary Grants for Electric Vehicles Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1227

Introduced
2/12/25  
Alternatives to PAIN Act Alternatives to Prevent Addiction In the Nation Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HJR58

Introduced
2/12/25  
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies".
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1267

Introduced
2/12/25  
Refer
2/12/25  
Water Systems PFAS Liability Protection Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1254

Introduced
2/12/25  
Rural Obstetrics Readiness Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1239

Introduced
2/12/25  
Voluntary Sustainable Apparel Labeling Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HJR46

Introduced
2/12/25  
This joint resolution nullifies the Environmental Protection Agency rule relating to Decabromodiphenyl Ether and Phenol, Isopropylated Phosphate (3:1); Revision to the Regulation of Persistent, Bioaccumulative, and Toxic Chemicals Under the Toxic Substances Control Act (TSCA) (89 Fed. Reg. 91486) and published on November 19, 2024. Among other elements, the rule revised regulations for two of the five persistent, bioaccumulative, and toxic chemicals to address implementation issues and further reduce potential for exposures to such chemicals for humans and the environment (e.g., requiring the use of personal protective equipment during certain activities involving decabromodiphenyl ether). 
US

US Federal 2025-2026 Regular Session

US Federal House Bill HJR44

Introduced
2/12/25  
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "National Primary Drinking Water Regulations for Lead and Copper: Improvements (LCRI)".
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1244

Introduced
2/12/25  
Reducing Drug Prices for Seniors Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1291

Introduced
2/13/25  
HEARTS Act of 2025 Humane and Existing Alternatives in Research and Testing Sciences Act of 2025
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB1346

Introduced
2/13/25  
Refer
2/13/25  
Nationwide Consumer and Fuel Retailer Choice Act of 2025